Newsletter
Approval Launch
News filed under Approval/Launch, newest first.
Showing 1–5 of 10 stories
Latest story
FDA Approves Bayer’s Kerendia for Chronic Kidney Disease Linked to Type 1 Diabetes
Bayer has announced that the U.S. Food and Drug Administration (FDA) has approved Kerendia (finereno...
Read story
Glenmark Launches Calcium Gluconate Injection in the U.S., Expanding Its Hospital Injectable Portfolio
New Injectable Product Targets the U.S. Institutional Healthcare Market Glenmark Pharmaceuticals...
Read story
Ultragenyx Gets FDA Accelerated Approval for Genglycos Gene Therapy in GSDIa
First Approved Therapy From Ultragenyx Directly Targets the Root Cause of GSDIa Ultragenyx Pharma...
Read story
Lupin Receives U.S. FDA Approval for Sodium Zirconium Cyclosilicate Oral Suspension
New Generic Treatment Approved for Hyperkalemia in Adults Lupin Limited has received approval fro...
Read story
Merck Seeks FDA Approval to Expand Enflonsia Use for High-Risk Children During Their Second RSV Season
FDA Accepts Supplemental Application for Enflonsia Merck, known as MSD outside the United States...
Read storyPage 1 of 2
